BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
90 results:

  • 1. cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
    Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
    BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deubiquitinase BRCC3 promotes the migration, invasion and emt progression of colon adenocarcinoma by stabilizing MET expression.
    Feng X; He S; Chen Y; Zhang L
    Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
    Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
    Gene; 2024 May; 908():148304. PubMed ID: 38387708
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
    Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
    BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. H19: An Oncogenic Long Non-coding RNA in colorectal cancer.
    Chowdhury PR; Salvamani S; Gunasekaran B; Peng HB; Ulaganathan V
    Yale J Biol Med; 2023 Dec; 96(4):495-509. PubMed ID: 38161577
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CYP1B1-AS1 Delays the Malignant Progression of colorectal cancer by Binding with NOP58.
    Wu Z; Cheng F; Yuan L; Li X; Li Z; Huang Z; Mao S; Chen X; Wang J; Lai B; Shen W
    Dig Dis Sci; 2024 Feb; 69(2):437-452. PubMed ID: 38087130
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Role of non-coding RNAs as new therapeutic targets in regulating the emt and apoptosis in metastatic gastric and colorectal cancers.
    Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
    Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. SARS-CoV-2 S and N protein peptides drive invasion abilities of colon cancer cells through TGF-β1 regulation.
    Ciszewski WM; Wozniak LA; Sobierajska K
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119541. PubMed ID: 37468071
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The NF-Y splicing signature controls hybrid emt and ECM-related pathways to promote aggressiveness of colon cancer.
    Rigillo G; Belluti S; Campani V; Ragazzini G; Ronzio M; Miserocchi G; Bighi B; Cuoghi L; Mularoni V; Zappavigna V; Dolfini D; Mercatali L; Alessandrini A; Imbriano C
    Cancer Lett; 2023 Jul; 567():216262. PubMed ID: 37307894
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
    Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
    J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Single-Cell Sequencing-Based Validation of T Cell-Associated Diagnostic Model Genes and Drug Response in Crohn's Disease.
    Dai Z; Zhang J; Xu W; Du P; Wang Z; Liu Y
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047025
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma.
    Huang SC; Huang CC; Ko CY; Huang CY; Liu CH; Lee YK; Chen TY; Hsueh CW; Tzou SJ; Tai MH; Hu TH; Tsai MC; Lee WC; Ho YC; Wu CC; Chang YC; Chang JJ; Liu KH; Li CC; Wen ZH; Chang CL; Chu TH
    Gene; 2023 May; 865():147331. PubMed ID: 36871674
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for colorectal cancer Patients.
    Ghatak S; Satapathy SR; Sjölander A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Biological Effect of Small Extracellular Vesicles on colorectal cancer Metastasis.
    Wang X; Huang D; Wu J; Li Z; Yi X; Zhong T
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552835
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Abberant Immunohistochemical Expression of OCT3/4 and emt Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in colorectal Adenocarcinoma.
    Busuioc C; Birla RD; Ultimescu F; Duţulescu S; Panaitescu E; Berindan-Neagoe I
    Chirurgia (Bucur); 2022 Oct; 117(5):544-555. PubMed ID: 36318684
    [No Abstract]    [Full Text] [Related]  

  • 16. Capture of Heterogeneous Circulating Tumor Cells in colorectal cancer Patients on an Immunomagnetic and Anti-Nonspecific Adsorption Platform.
    Li C; Li R; Wu X; Zuo Y; Xiong G; Huang M; Sun Y; Liao R; Xiao Y; Hu L; Gao C; Yu Y
    Anal Chem; 2022 Nov; 94(44):15240-15249. PubMed ID: 36279553
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Oct4 promoted proliferation, migration, invasion, and epithelial-mesenchymal transition (emt) in colon cancer cells by activating the SCF/c-Kit signaling pathway.
    Bu X; Liu Y; Wang L; Yan Z; Xin G; Su W
    Cell Cycle; 2023 Feb; 22(3):291-302. PubMed ID: 36258646
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. B7-H4 is a potential diagnostic and prognostic biomarker in colorectal cancer and correlates with the epithelial-mesenchymal transition.
    Yan X; Hong B; Feng J; Jin Y; Chen M; Li F; Qian Y
    BMC Cancer; 2022 Oct; 22(1):1053. PubMed ID: 36217128
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of cancers.
    Yang X; Li C; Chen Y
    Curr Cancer Drug Targets; 2023; 23(3):171-186. PubMed ID: 36043756
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PD-L1 Expression in colorectal Adenocarcinoma Is Associated With the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition.
    Secinti IE; Ozgur T; Dede I
    Am J Clin Pathol; 2022 Oct; 158(4):506-515. PubMed ID: 35938631
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.